Failure of the tyrosine kinase inhibitors osimertinib and erlotinib to manage a patient with EGFR-mutant lung adenocarcinoma: a case report

Malik W. Z. Khan, Muhammad Ahmad, Salma Qudrat, Long Tu, Salman Khan, Ekrem Yetiskul, Samra Iftikhar